Intellectual Property India Publishes Patent Application for 'Prodrugs Of Thyroid Hormone Analogs, Methods Of Making And Methods Of Using Thereof' Filed by Ascletis Pharma (CHINA) Co. Limited

MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202527077782 A) filed by Ascletis Pharma (CHINA) Co. Limited, Hong Kong, on Aug. 14, for 'prodrugs of thyroid hormone analogs, methods of making and methods of using thereof.'

Inventor(s) include Wu, Jinzi, Jason; and Liang, Bin.

The application for the patent was published on Sept. 5, under issue no. 36/2025.

According to the abstract released by the Intellectual Property India: "The present application describes a thyroid hormone receptor [3 subtype agonist derivative, a preparation method and a use thereof."

The patent application was internationally filed on Feb. 06, 2024, under International application No.PCT/US2024/014668.

Disclaimer: Curated by HT Syndication.